Clustering-aided prediction of outcomes in patients with idiopathic pulmonary fibrosis.
Lijun Wang, Peitao Wu, Yi Liu...
https://pubmed.ncbi.nlm.nih.gov/39443991/Actively Recruiting
Led by Duke University · Updated on 2026-08-12
3000
Participants Needed
47
Research Sites
156 weeks
Total Duration
Researchers are studying Idiopathic Pulmonary Fibrosis IPF and other chronic fibrosing interstitial lung diseases ILDs with a progressive phenotype through the IPF-PRO and ILD-PRO Registries. This prospective registry collects data on the natural history, healthcare experiences, quality of life, and treatments of participants diagnosed with IPF or other chronic fibrosing ILDs. Blood samples and chest imaging studies are also gathered and stored for future research. The registry originally enrolled over 1000 participants with IPF and expanded to include other fibrosing ILDs with progressive phenotypes, aiming to enroll up to 1000 additional patients in each phase.
CONDITIONS
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
R
Rosalia Blanco
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Duke University
Lead Sponsor
Boehringer Ingelheim
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 3 to 5 years depending on cohort
Participants provide health information, complete questionnaires about quality of life, and undergo collection of blood samples and chest imaging for research. Their treatment is managed by their healthcare providers.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Lijun Wang, Peitao Wu, Yi Liu...
https://pubmed.ncbi.nlm.nih.gov/39443991/Ross Summer, Jamie L Todd, Megan L Neely...
https://pubmed.ncbi.nlm.nih.gov/38273290/Megan L Neely, Anne S Hellkamp, Shaun Bender...
https://pubmed.ncbi.nlm.nih.gov/37612608/Peifeng Ruan, Jamie L Todd, Hongyu Zhao...
https://pubmed.ncbi.nlm.nih.gov/37344825/Aparna C Swaminathan, Jeremy M Weber, Jamie L Todd...
https://pubmed.ncbi.nlm.nih.gov/40022059/Emily C O'Brien, Anne S Hellkamp, Megan L Neely...
https://pubmed.ncbi.nlm.nih.gov/31954102/Laurie Snyder, Megan L Neely, Anne S Hellkamp...
https://pubmed.ncbi.nlm.nih.gov/31142314/Hyun J Kim, Laurie D Snyder, Ayodeji Adegunsoye...
https://pubmed.ncbi.nlm.nih.gov/34592998/Jamie L Todd, Megan L Neely, Robert Overton...
https://pubmed.ncbi.nlm.nih.gov/31640794/Sharashchandra Shetty, Aparna C Swaminathan, Peide Li...
https://pubmed.ncbi.nlm.nih.gov/42201372/Duke University
Lead Sponsor
Boehringer Ingelheim
Collaborating Sponsor